Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Alnylam Pharmaceuticals
(NQ:
ALNY
)
166.75
USD
UNCHANGED
Streaming Delayed Price
Updated: 6:45 AM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Alnylam Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
3 Lesser-Known Biotech Stocks that are Surging
January 21, 2021
Biotechnology was one of the most popular sectors in 2020. The coronavirus pandemic drew attention to the sector due to the urgent need for COVID-19 testing supplies and a vaccine.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
First Week of September 17th Options Trading For Alnylam Pharmaceuticals (ALNY)
January 15, 2021
Investors in Alnylam Pharmaceuticals Inc (ALNY) saw new options become available this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NK
STIM
NARI
From
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
January 11, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...
Tags
Options
CORT
BZI/AUOA
From
Benzinga
Alnylam Launches “Alnylam P5x25” Strategy For Planned Transition To A Top Five Biotech In Market Capitalization Over Next Five Years
January 10, 2021
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced its new five-year strategy, “Alnylam P5x25,” which is focused on the company’s transition to a top-5 biotech (measured by...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Notable Friday Option Activity: ALNY, LULU, UI
January 08, 2021
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Alnylam Pharmaceuticals Inc (ALNY), where a total volume of 4,762 contracts has...
Tags
Stocks
From
Market News Video
Alnylam Pharmaceuticals Larger Than S&P 500 Component IDEX
December 31, 2020
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Alnylam Pharmaceuticals Inc (ALNY) was identified as having a larger market cap than the smaller end of the...
Tags
Stocks
From
Market News Video
Analysts Forecast 10% Gains Ahead For The Holdings of BBH
December 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Interesting ALNY Put And Call Options For February 2021
December 21, 2020
Investors in Alnylam Pharmaceuticals Inc (ALNY) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Should You Buy Sage Stock After the Biogen Investment?
December 19, 2020
Each company has suffered a clinical failure recently, but this team-up could do good things for both.
Tags
ALNY
BIIB
SAGE
From
Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
The FDA's inability to inspect an overseas manufacturing facility is holding up an application for inclisiran.
Tags
Market News
AMGN
SNY
From
Motley Fool
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AUPH
BEAM
MRK
From
Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
Multiple drugmakers gained FDA approval last week.
Tags
ALNY
Market News
LLY
From
Motley Fool
Are These The Best Biotech Stocks To Watch Right Now? 3 To Consider As Pfizer’s Vaccine Rollout Begins
December 02, 2020
From
Stockmarket.com
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
The company's rare disease treatments are a huge success and there will probably be a lot more of them.
Tags
ALNY
NVS
Market News
From
Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
The company's rare disease treatments are a huge success and there will probably be a lot more of them.
Tags
NVS
ALNY
SNY
From
Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ...
Tags
Health Care
IMV
Market News
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
November 28, 2020
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ...
Tags
OSMT
ALKS
Market News
From
Benzinga
Why These 3 Pharma Stocks Are Moving Today
November 24, 2020
Alnylam Pharmaceuticals (NASDAQ: ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has ...
Tags
News
Penny Stocks
ARWR
From
Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
CORT
SPRO
From
Benzinga
The Math Shows FXH Can Go To $112
November 18, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
APVO
BIIB
BCRX
From
Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
PFE
OFIX
AGIO
From
Benzinga
Notable Monday Option Activity: AX, ALNY, GME
October 26, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Axos Financial Inc (AX), where a total volume of 1,220 contracts has been traded...
Tags
Stocks
From
Market News Video
Alnylam Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ALNY
October 23, 2020
In trading on Friday, shares of Alnylam Pharmaceuticals Inc (ALNY) crossed below their 200 day moving average of $132.25, changing hands as low as $130.78 per share. Alnylam Pharmaceuticals Inc shares...
Tags
Stocks
From
Market News Video
12 Healthcare Stocks Moving In Thursday's After-Market Session
October 22, 2020
Gainers Cassava Sciences (NASDAQ:SAVA) stock rose 20.61% to $10.65 during Thursday's after-market session. Today's trading ...
Tags
NVIV
General
BCDA
From
Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
OMER
Market News
ADCT
From
Benzinga
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
October 18, 2020
Biopharma stocks, which started the week on a firm footing, lost momentum mid-way through amid market-wide sell-off triggered by waning stimulus hopes.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
October 18, 2020
Biopharma stocks, which started the week on a firmfooting, lost momentum mid-way through amid market-wide sell-off triggered by ...
Tags
ZSAN
SYRS
ALRN
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.